Furthermore, PD-1 inhibitors might directly kill hepatocytes through complement-mediated tissue inflammation and induction of cytokine secretion by immune cells [29, 30]; TKIs can directly damage hepatocytes, cause cholestasis and mediate hepatocyte steatosis, all of which can further aggravate liver injury. This evidence concerns the gene PDCD1 and cholestasis.